Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

10 Stocks on a Bankruptcy Watch

By Josh Enomoto, InvestorPlace Contributor

It’s no secret that the coronavirus pandemic has brought the global economy to its knees. But some companies have been hurt more than others, like these stocks to sell which might also suffer on a more permanent basis.

Why the Coronavirus Is a Double-Edged Sword for Aurora Cannabis

By Josh Enomoto, InvestorPlace Contributor

Beaten up for most of this year, Aurora stock finally looks interesting after encouraging results from the company’s fiscal Q3 earnings report. While still incredibly risky, ACB can move higher based on longer-term developments.

Visa Stock Jumped on Positive Vaccine News But It’s Not All That

By Josh Enomoto, InvestorPlace Contributor

With the possibility of an effective coronavirus vaccine recently revealed, blue-chip investments like V stock jumped higher. Still, the fine print suggests prospective buyers should remain cautious.

If Nio Skyrockets, You May Want to Thank President Trump

By Josh Enomoto, InvestorPlace Contributor

A lack of comprehensive EV infrastructure was among the many headwinds impacting Nio stock. But post-coronavirus, geopolitical rumblings may benefit NIO and other Chinese EV makers.

Marathon Oil Still Has a Long Way to Run Despite the Vaccine

By Josh Enomoto, InvestorPlace Contributor

The beleaguered oil market needs a lifeline and it may have gotten one from Moderna’s coronavirus vaccine. However, before diving into independent names like MRO stock, be sure to understand the risks.

3 Things You Should Know About Gold Stocks

By Josh Enomoto, InvestorPlace Contributor

Given the turmoil and uncertainty in the global economy, there’s never been a better time to consider gold stocks. However, you should also be aware of the risks to know if this sector is truly right for you.

SmileDirectClub Is a Luxury That Few Care About in a Recession

By Josh Enomoto, InvestorPlace Contributor

While SmileDirectClub is part of the burgeoning telehealth movement, SDC stock has disappointed investors because of its underlying elective service.

If Free Money Can’t Save Big Oil, Exxon Mobil Is Tough to Justify

By Josh Enomoto, InvestorPlace Contributor

While Exxon Mobil stock has dropped to staggering depths, that’s about the only positive for contrarians. Unfortunately, if “free” money can’t lift XOM, the oil markets may stay deflated for a long time.

American Airlines Could Crash, But Is It the Only One?

By Josh Enomoto, InvestorPlace Contributor

With so much blood in the airlines industry, many have pointed the finger at AAL stock as a possible candidate for implosion. But just how many other rivals can survive the coming onslaught?

Why JPMorgan Chase Isn’t Safe From the Onslaught

By Josh Enomoto, InvestorPlace Contributor

In theory, JPM stock is a stable investment due to its underlying strengths and influence. However, without a meaningful recovery in the economy, it’s just as risky as anything else.

Load More